GH receptor
9 drugs6
approved indications
9
Approved Drugs
7
Companies
10
Indications
0
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (7 companies)
✓ All 9 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (10 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
PHARMACIA 2 drugs
Novo Nordisk 2 drugs
Roche 1 drug
By Therapeutic Area
Other 9 drugs
Drugs by Company PRO
PHARMACIA 2 drugs
Novo Nordisk 2 drugs
Roche 1 drug
EMD SERONO 1 drug
Novartis 1 drug
FERRING 1 drug
Pfizer 1 drug
By Therapeutic Area
Other 9 drugs
GENOTROPIN PRESERVATIVE FREE, NUTROPIN AQ NUSPIN, NORDITROPIN FLEXPRO, SAIZEN +5 more
Indications Treated
Growth Hormone DeficiencyGrowth FailureShort StatureNoonan SyndromeTurner SyndromeSmall for Gestational AgePrader-Willi SyndromeIdiopathic Short StatureAcromegalyShort Stature Homeobox-Containing Gene Deficiency
All Drugs Targeting GH receptor
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| GENOTROPIN PRESERVATIVE FREE Top | PHARMACIA | 1995 | 6 | |
| NUTROPIN AQ NUSPIN Top | Roche | 1995 | 6 | |
| NORDITROPIN FLEXPRO Top | Novo Nordisk | 2000 | 6 | |
| SAIZEN | EMD SERONO | 1996 | 6 | |
| OMNITROPE | Novartis | 2006 | 5 | |
| ZOMACTON | FERRING | 1995 | 5 | |
| SOGROYA | Novo Nordisk | 2020 | 2 | |
| SOMAVERT | PHARMACIA | 2003 | 1 | |
| NGENLA | Pfizer | 2023 | 1 |